Table 3.

Biomarkers according to VTE recurrence at 6 months

	Total cohort (n = 114), n (%)	No VTE recurrence (n = 104), n (%)	VTE recurrence (n = 10), n (%)	p
Metastasis	45 (39.8)	39 (37.9)	6 (60)	0.17
Biomarkers
Baseline D-dimer (n = 111), median ng/mL (IQR)	333 (217–696)	327 (215–644)	615 (246–1112)	0.22
D-dimer at 21 days (n = 111), median ng/mL (IQR)	524 (374–1126)	486 (352–1046)	1701 (827–4034)	0.002
Baseline hs-CRP (n = 99), median mg/L (IQR)	2.7 (1.4–7)	2.4 (1.3–7.2)	4.6 (2.3–7.1)	0.28
hs-CRP at 21 days (n = 103), median mg/L (IQR)	2.6 (1.5–7)	2.5 (1.4–6.4)	8.4 (5.6–16.2)	0.002

VTE venous thromboembolism, IQR interquartile range, hs-CRP high-sensitivity C-reactive protein. Bold indicates that p was statistically significant. If you consider can be eliminated